Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B

doi:10.3748/wjg.v27.i40.6927

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 40

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5725)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

354

WORD

124

HTML

2927

Figures (1-5)

209

Tables (1-1)

400

Sum=4014

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

432

Download

1279

Sum=1711

Oct 28, 2021 (publication date) through Nov 15, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Oct 28, 2021; 27(40): 6927-6938
Published online Oct 28, 2021. doi: 10.3748/wjg.v27.i40.6927

Full Size Figure Download Figure

Figure 2 Time-dependent distribution of serum quantitative hepatitis B core-related antigen in patients with chronic hepatitis B and treated with different regimens. A: Changes in hepatitis B core-related antigen (HBcrAg) levels during treatment in the entecavir group; B: Changes in HBcrAg levels during treatment in the peginterferon group; C: Changes in HBcrAg levels during treatment in all patients; D: Comparison of the decrease in HBcrAg levels from baseline to week 48 between the entecavir and peginterferon groups. ^cP < 0.0001. HBcrAg: Hepatitis B core-related antigen; IFN: Interferon.

Citation: Chi XM, Wang XM, Wang ZF, Wu RH, Gao XZ, Xu HQ, Ding YH, Niu JQ. Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B. World J Gastroenterol 2021; 27(40): 6927-6938
URL: https://www.wjgnet.com/1007-9327/full/v27/i40/6927.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i40.6927